Top Markets
#1 Siren Siren +34.84%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.77%
#3 Ribbita by Virtuals Ribbita by Virtuals +20.39%
#4 Wiki Cat Wiki Cat +20.32%
#5 Cysic Cysic +17.67%
#6 PulseChain PulseChain +16.52%
#7 Velvet Velvet +16.46%
#8 The Grays Currency The Grays Currency +16.46%
#9 KUB Coin KUB Coin +16.41%
#10 Bitway Bitway +14.33%
Coin of the day
Siren Siren
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Classifica tra le azioni #31074
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Prezzo delle azioni
$0.404
Capitalizzazione di mercato
$14.28M
Variazione (1 giorno)
-10.42%
Variazione (1 anno)
-67.68%
Paese
IL
Scambia NeuroSense Therapeutics Ltd. (NRSN)

Categoria

Healthcare
Ricavi di NeuroSense Therapeutics Ltd. (NRSN)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di NeuroSense Therapeutics Ltd., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per NeuroSense Therapeutics Ltd. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE